Stoke Therapeutics, Inc. (STOK)
USD 11.11
(-8.18%)
USD 11.11
(-8.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.78 Million | 12.4 Million | - | - | - | - |
| Cost of Revenue | 4.72 Million | 3.53 Million | 2.23 Million | 1.92 Million | 450 Thousand | 214 Thousand |
| Gross Profit | 4.05 Million | 8.87 Million | -2.23 Million | -1.92 Million | -450 Thousand | -214 Thousand |
| Operating Expenses | 123.55 Million | 116.76 Million | 86.06 Million | 53.04 Million | 35.67 Million | 12.78 Million |
| Selling, General and Administrative Expenses | 41.32 Million | 38.92 Million | 31.89 Million | 20.84 Million | 11.91 Million | 4.41 Million |
| Research and Development Expenses | 82.23 Million | 77.83 Million | 54.16 Million | 32.19 Million | 23.76 Million | 8.37 Million |
| Other Expenses | - | 167 Thousand | 140 Thousand | 57 Thousand | 2000.00 | -10 Thousand |
| Cost and Expenses | 123.55 Million | 116.76 Million | 86.06 Million | 53.04 Million | 35.67 Million | 12.78 Million |
| Operating Income | -114.77 Million | -104.35 Million | -86.06 Million | -53.04 Million | -35.67 Million | -12.78 Million |
| Interest Expense | - | 3.12 Million | 120 Thousand | - | - | - |
| Income Tax Expense | - | -7.95 Million | -1.09 Million | -1.63 Million | -3.8 Million | 260 Thousand |
| Earnings before Tax | -104.69 Million | -101.06 Million | -85.8 Million | -52.24 Million | -32.32 Million | -12.52 Million |
| Net Income | -104.69 Million | -93.11 Million | -84.71 Million | -50.61 Million | -28.52 Million | -12.52 Million |
| Earnings Per Share Basic | -2.38 | -2.39 | -2.31 | -1.51 | -1.59 | -0.53 |
| Earnings Per Share Diluted | -2.38 | -2.39 | -2.31 | -1.51 | -1.59 | -0.53 |
| Weighted Average Shares Outstanding | 43.99 Million | 38.89 Million | 36.73 Million | 33.48 Million | 17.97 Million | 23.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.99 Million | 38.89 Million | 36.73 Million | 33.48 Million | 17.97 Million | 23.51 Million |
| Gross Margin | 0.46 | 0.72 | - | - | - | - |
| EBIT Margin | -12.79 | -8.41 | - | - | - | - |
| Profit Margin | -11.92 | -7.51 | - | - | - | - |
| EBITDA | -112.3 Million | -102.81 Million | -83.57 Million | -50.31 Million | -35.22 Million | -12.56 Million |
| Earnings Before Tax Margin | -13.07 | -8.41 | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 4.89 Million | 4.83 Million | 4.21 Million | 2.8 Million | 8.78 Million | 3.3 Million |
| Cost of Revenue | - | 1.11 Million | 1.11 Million | 1.21 Million | 4.72 Million | 1.2 Million |
| Gross Profit | 4.89 Million | 3.72 Million | 3.1 Million | 1.58 Million | 4.05 Million | 2.1 Million |
| Operating Expenses | 34.89 Million | 33.06 Million | 31.47 Million | 31.17 Million | 118.82 Million | 30.54 Million |
| Selling, General and Administrative Expenses | 12.69 Million | 12.47 Million | 9.67 Million | 10.01 Million | - | 10.27 Million |
| Research and Development Expenses | 22.2 Million | 20.58 Million | 21.8 Million | 21.15 Million | - | 20.27 Million |
| Other Expenses | - | -48 Thousand | -428 Thousand | 41 Thousand | 166 Thousand | 41 Thousand |
| Cost and Expenses | 34.89 Million | 34.17 Million | 32.58 Million | 32.38 Million | 123.55 Million | 30.54 Million |
| Operating Income | -30 Million | -29.34 Million | -28.37 Million | -29.58 Million | -114.77 Million | -27.23 Million |
| Interest Expense | 3.54 Million | 3.69 Million | 2.42 Million | 2.58 Million | 9.9 Million | 2.65 Million |
| Income Tax Expense | - | - | 1.06 Million | 10.71 Million | 4.56 Million | -3.28 Million |
| Earnings before Tax | -26.43 Million | -25.69 Million | -26.37 Million | -26.95 Million | -104.69 Million | -24.54 Million |
| Net Income | -26.43 Million | -25.69 Million | -26.37 Million | -26.95 Million | -104.69 Million | -24.54 Million |
| Earnings Per Share Basic | -0.47 | -0.46 | -0.57 | -0.60 | - | -0.55 |
| Earnings Per Share Diluted | -0.47 | -0.46 | -0.57 | -0.60 | - | -0.55 |
| Weighted Average Shares Outstanding | 56.34 Million | 55.76 Million | 46.24 Million | 44.95 Million | 43.99 Million | 44.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.34 Million | 55.76 Million | 46.24 Million | 44.95 Million | 43.99 Million | 44.26 Million |
| Gross Margin | 1.00 | 0.77 | 0.74 | 0.57 | 0.46 | 0.64 |
| EBIT Margin | -6.13 | -5.84 | -6.47 | -10.13 | - | -8.23 |
| Profit Margin | -5.40 | -5.32 | -6.26 | -9.62 | -11.92 | -7.42 |
| EBITDA | -30 Million | -28.23 Million | -27.25 Million | -28.37 Million | - | -27.23 Million |
| Earnings Before Tax Margin | -6.13 | -6.07 | -6.73 | -10.56 | -13.07 | -8.23 |
BOI
LTIM
INDUSINDBK
DILD
PIC
OILCF